Bupropion Hydrochloride
- Product NDC
- 63629-8475
- 11-digit product format
- 636298475
- Labeler code
- 63629
- Product ID
- 63629-8475_fb604f37-45d9-4fe0-bce9-24bb6a045a14
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bupropion hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA207479
- Marketing category
- ANDA
- Marketing start
- 2017-04-12
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207479-001 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | |
| A207479-002 | BUPROPION HYDROCHLORIDE | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A207479-001 | AB3 |
| A207479-002 | AB3 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A207479-001 | BUPROPION HYDROCHLORIDE | 150MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A207479-002 | BUPROPION HYDROCHLORIDE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB3 | 2017-04-12 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A207479-001 | AB3 | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A207479-002 | AB3 | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | REMEDYREPACK INC. | 4cc3327b-92c5-4667-ae16-3e95eafcf4d8 | 2026-07-27 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 30c370c2-f2b7-4335-ba55-e8c8f4059092 | 2026-07-24 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | Bryant Ranch Prepack | 8499470a-8d01-4348-b67b-8f49728031cb | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | Bryant Ranch Prepack | cefaaa17-f79a-4ba6-8f97-a59f60e07b75 | 2026-05-28 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | REMEDYREPACK INC. | 0cd6e0e2-6b2c-4e0d-b5b2-ebfe0d5e31c4 | 2026-05-05 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | Bryant Ranch Prepack | 96e78f74-fad0-4ae1-9e68-55e4c6ab2d60 | 2026-04-09 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | Bryant Ranch Prepack | 03b1b0a9-0aa2-4039-acce-68ca54abaae4 | 2026-04-08 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | Bryant Ranch Prepack | a5417808-f767-48fc-9f5d-c1aeee4e57c3 | 2026-04-08 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 63629-8475 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | Bryant Ranch Prepack | a7553281-be90-47e3-8d2b-b027f6d18d3a | 2026-03-31 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | RADHA PHARMACEUTICALS, INC. | 16a788ff-8bd5-4f70-a3fd-a89db019e435 | 2026-02-03 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | ScieGen Pharmaceuticals,Inc. | 05f82eca-cc87-4580-acd7-e6491c651881 | 2026-02-02 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | Northwind Health Company, LLC | 4ddf6ba2-c020-7912-e063-6394a90a7964 | 2026-01-12 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 459bd1c9-d7a5-8bc9-e063-6394a90a8ecd | 2025-12-10 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride | BUPROPION HYDROCHLORIDE | A-S Medication Solutions | 722650d8-5ee4-48ba-9827-7c86b1283522 | 2025-10-16 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride | BUPROPION HYDROCHLORIDE | A-S Medication Solutions | 16ffe2ac-4f71-4843-99df-611f53c2f3cd | 2025-10-16 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | Advanced Rx of Tennessee, LLC | 3d826804-6427-aae1-e063-6394a90a6593 | 2025-08-29 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | Quality Care Products, LLC | 57a9f4d3-0c41-4978-b81e-cf3059bc8c42 | 2024-12-19 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | A-S Medication Solutions | 0ac739de-ad59-4882-810e-f52db22ac96f | 2024-10-16 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride (XL) | BUPROPION HYDROCHLORIDE | A-S Medication Solutions | d6efb695-c439-48d7-a155-5c661a5049af | 2024-10-16 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
| Bupropion Hydrochloride | BUPROPION HYDROCHLORIDE | Cipla USA., Inc. | 0abd64f7-5142-48f6-a487-3f5bdc3400de | 2023-10-19 | Boxed warning, Warnings, Adverse reactions | 207479 ANDA207479 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Bupropion Hydrochloride
- Brand name suffix
- (XL)
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BUPROPION HYDROCHLORIDE | 300 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| ZG7E5POY8O | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 993557 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| a5417808-f767-48fc-9f5d-c1aeee4e57c3 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 4eceb285-f3c7-4092-a21a-4c9f3169f20c | Product name | 5 | 20260220 |
| 548ba7fd-fd0c-4a21-b2b0-d01bf93143b8 | Product name | 3 | 20240209 |
| 43a1ed49-eae2-4840-8075-cb4b33478540 | Product name | 1 | 20230425 |
| b8ee525f-67fb-39fb-91da-7e47ac54581d | Product name | 5 | 20200611 |
| 98e65af1-f5d0-75d5-c930-f8a4ce4c3284 | Product name | 9 | 20190211 |
| e4d463bc-c674-43cb-be06-82786f310d01 | Product name | 1 | 20150326 |
| 0916dcfb-331f-89b1-8eac-6f7dc76d82da | Product name | 1 | 20140508 |
| d7fc3d53-5a6c-de82-2808-1780f175f17e | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63629-8475-1 | Bupropion Hydrochloride(XL) | 500 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED, EXTENDED RE | 500 | 104 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63629-8475-1 | EA - Each | 63629-8475 | 3cc78a82-fde3-4dd2-a710-8e3467151a3b | 1 | 2021-07-15 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63629-8475 | BUPROPION HYDROCHLORIDE (XL) (BUPROPION HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 103 | Current NDC, Legacy NDC, 1 package rows | 20240112_a5417808-f767-48fc-9f5d-c1aeee4e57c3.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 993557 | buPROPion HCl 300 MG 24HR Extended Release Oral Tablet | PSN | a5417808-f767-48fc-9f5d-c1aeee4e57c3 | 104 |
| 993557 | 24 HR bupropion hydrochloride 300 MG Extended Release Oral Tablet | SCD | a5417808-f767-48fc-9f5d-c1aeee4e57c3 | 104 |
| 993557 | bupropion HCl XL 300 MG 24 HR Extended Release Oral Tablet | SY | a5417808-f767-48fc-9f5d-c1aeee4e57c3 | 104 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 63629-8475-1 | 63629847501 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63629-8475-1) | 2017-04-12 | 0000-00-00 | No | No | Current |